PoddsändningarVetenskapThe Long Run with Luke Timmerman

The Long Run with Luke Timmerman

Timmerman Report
The Long Run with Luke Timmerman
Senaste avsnittet

192 avsnitt

  • The Long Run with Luke Timmerman

    Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery

    2026-02-17 | 1 h 8 min.
    Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery by Timmerman Report
  • The Long Run with Luke Timmerman

    Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines

    2026-01-22 | 1 h 5 min.
    Ron Renaud, CEO of Waltham, Mass.-based Kailera Therapeutics, on developing GLP-1 based medicines to help people lose weight and live healthier lives.
  • The Long Run with Luke Timmerman

    Ep192: Kate Haviland on Following the Science to Precision Immunology

    2026-01-08 | 1 h 26 min.
    Kate Haviland, former CEO of Blueprint Medicines, on how the company transitioned to a precision immunology company and was acquired by Sanofi for $9.5 billion.
  • The Long Run with Luke Timmerman

    Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease

    2025-12-15 | 1 h 7 min.
    Emily Conley, CEO of Berkeley, CA-based Renasant Bio, on developing small molecule correctors and potentiators for autosomal dominant polycystic kidney disease (ADPKD).
  • The Long Run with Luke Timmerman

    Ep190: Neil Kumar on Building a Rare Disease Drug Company

    2025-11-20 | 1 h 13 min.
    Neil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.

Fler podcasts i Vetenskap

Om The Long Run with Luke Timmerman

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Podcast-webbplats

Lyssna på The Long Run with Luke Timmerman, Naturmorgon och många andra poddar från världens alla hörn med radio.se-appen

Hämta den kostnadsfria radio.se-appen

  • Bokmärk stationer och podcasts
  • Strömma via Wi-Fi eller Bluetooth
  • Stödjer Carplay & Android Auto
  • Många andra appfunktioner
Sociala nätverk
v8.7.2 | © 2007-2026 radio.de GmbH
Generated: 3/3/2026 - 4:21:33 AM